A Stoehr
Overview
Explore the profile of A Stoehr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Funke B, Spinner C, Esser S, Stellbrink H, Stoehr A, Wolf E, et al.
Int J STD AIDS
. 2020 Nov;
32(1):75-82.
PMID: 33236659
Recreational drug use is higher in people living with HIV (PLHIV) than in the general population in Europe. This use increases the risk for drug-drug interactions (DDIs) and adverse events....
2.
Fatkenheuer G, Jessen H, Stoehr A, Jung N, Jessen A, Kummerle T, et al.
HIV Med
. 2016 May;
17(6):453-9.
PMID: 27166295
Objectives: PEPDar compared the tolerability and safety of ritonavir-boosted darunavir (DRV/r)-based post-exposure prophylaxis (PEP) with the tolerability and safety of standard of care (SOC). The primary endpoint was the early...
3.
Mayr H, Stoehr A
Orthopade
. 2015 Oct;
45(1):4-12.
PMID: 26486644
Background: Today, knee arthroscopy is one of the standard interventions performed by an orthopaedist and usually has a low potential for complications. Purpose: The surgeon should still be aware of...
4.
Hoffmann C, Hentrich M, Gillor D, Behrens G, Jensen B, Stoehr A, et al.
HIV Med
. 2014 Sep;
16(4):261-4.
PMID: 25252101
Objectives: The incidence of HIV-related non-Hodgkin lymphoma (NHL) but not that of Hodgkin lymphoma (HL) has been declining. The aim of the study was to compare HIV-infected patients with NHL...
5.
Thoden J, Potthoff A, Bogner J, Brockmeyer N, Esser S, Grabmeier-Pfistershammer K, et al.
Infection
. 2013 Sep;
41 Suppl 2:S91-115.
PMID: 24037688
Introduction: There was a growing need for practical guidelines for the most common OIs in Germany and Austria under consideration of the local epidemiological conditions. Materials And Methods: The German...
6.
Orkin C, DeJesus E, Khanlou H, Stoehr A, Supparatpinyo K, Lathouwers E, et al.
HIV Med
. 2012 Oct;
14(1):49-59.
PMID: 23088336
Objective: This paper presents the final analysis of once-daily darunavir/ritonavir (DRV/r) vs. lopinavir/ritonavir (LPV/r) in treatment-naïve HIV-1-infected adults. Methods: ARTEMIS (AntiRetroviral Therapy with TMC114 ExaMined In naïve Subjects; NCT00258557) was...
7.
Knechten H, Stephan C, Mosthaf F, Jaeger H, Lutz T, Cargnico A, et al.
Infection
. 2010 Mar;
38(2):108-16.
PMID: 20352287
Background: The RAINBOW survey is a multinational observational study assessing the tolerability and efficacy of ritonavir-boosted saquinavir (SQV/r), using the 500-mg film-coated SQV formulation, in routine clinical practice. This analysis...
8.
Lorenzen T, Walther I, Stoehr A, Salzberger B, Plettenberg A
Infection
. 2009 Oct;
37(6):528-33.
PMID: 19826762
Background: Clinical studies suggest expert recommendations as a possibility to optimize highly active antiretroviral therapy (HAART) in patients with multi-drug resistant virus strains. An online system (RADATA) has been developed...
9.
Hoffmann C, Ernst M, Meyer P, Wolf E, Rosenkranz T, Plettenberg A, et al.
Clin Microbiol Infect
. 2007 Feb;
13(5):510-5.
PMID: 17298486
Toxoplasmic encephalitis (TE) is the most important opportunistic infection of the central nervous system in patients infected with human immunodeficiency virus (HIV)-1. This study evaluated the effect of highly active...
10.